Supply of Medicinal Products
Original notice title
Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Dostawa produktów leczniczych
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Szpital Specjalistyczny im. Jędrzeja Śniadeckiego
- Country
- Poland
- CPV
- 33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
- Deadline
- Nov 04, 2026
- Estimated value
- PLN 23.3M (approx. EUR 5.3M)
AI tender analysis
Tenderwize prepares an AI analysis of this tender based on the TED notice and procurement documents: scope of work, key requirements, eligibility criteria, risks and questions for the buyer. The analysis is generated when the tender is opened.
Award Criteria
Lot 1
Lot 2
Lot 3
Lot 4
Lot 5
Lot 6
Lot 7
Lot 8
Lot 9
Lot 10
Lot 11
Lot 12
Lot 13
Lot 14
Lot 15
Lot 16
Lot 17
Lot 18
Lot 19
Lot 20
Lot 21
Lot 22
Lot 23
Lot 24
Lot 25
Lot 26
Lot 27
Lot 28
Lot 29
Lot 30
Lot 31
Buyer
Location
Nowy Sącz, POL
Website
Identifier
7342608458
Activity
Health
Lots (31)
LOT-0001
Część nr 1: Tafasitamab
Tafasitamab
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0002
Część nr 2: Awatrombopag
Awatrombopag
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0003
Część nr 3: Ibrutynib
Ibrutynib
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0004
Część nr 4: Daratumumab
Daratumumab
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0005
Część nr 5: Awaprytynib
Awaprytynib
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0006
Część nr 6: Rybocyklib
Rybocyklib
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0007
Część nr 7: Alpelisyb
Alpelisyb
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0008
Część nr 8: Darolutamid
Darolutamid
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0009
Część nr 9: Gilterytynib
Gilterytynib
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0010
Część nr 10: Sotorasib
Sotorasib
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0011
Część nr 11: Tukatynib
Tukatynib
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0012
Część nr 12: Trastuzumab derukstekan
Trastuzumab derukstekan
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0013
Część nr 13: Izatuksymab
Izatuksymab
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0014
Część nr 14: Zanubrutynib
Zanubrutynib
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0015
Część nr 15: Esketamina
Esketamina
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0016
Część nr 16: Dostarlimab
Dostarlimab
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0017
Część nr 17: Kaplacyzumab
Kaplacyzumab
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0018
Część nr 18: Fruquintinibum
Fruquintinibum
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0019
Część nr 19: Tremelimumabum
Tremelimumabum
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0020
Część nr 20: Tislelizumabum
Tislelizumabum
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0021
Część nr 21: Amiwantamab
Amiwantamab
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0022
Część nr 22: Lazertynib
Lazertynib
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0023
Część nr 23: Serplulimab
Serplulimab
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0024
Część nr 24: Binimetynib
Binimetynib
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0025
Część nr 25: Enkorafenib
Enkorafenib
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0026
Część nr 26: Kapiwasertyb
Kapiwasertyb
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0027
Część nr 27: Mosunetuzumab
Mosunetuzumab
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0028
Część nr 28: Glofitamab
Glofitamab
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0029
Część nr 29: Cabozantinibum
Cabozantinibum
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0030
Część nr 30: Immunoglobuliny
Immunoglobuliny
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
LOT-0031
Część nr 31: Immunoglobuliny
Immunoglobuliny
EUR 5.3M
Estimated value
Location
Duration
Category
Award Criteria
Award details
cena
Procurement Details
- Publication date
- 29 Oct 2026
- Languages
- Polish
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 753891-2026
Documents (1)
Similar tenders
Romania – Pharmaceutical products – ACORD CADRU FURNIZARE MEDICAMENTE PENTRU 12 LUNI - 2027 - 2028
Latvia – Pharmaceutical products – Medikamentu iegāde CHIP-AML22 projekta realizācijai
Poland – Pharmaceutical products – „Dostawa produktów leczniczych, środków specjalnego przeznaczenia żywieniowego, wyrobów medycznych, glukometrów, płynów kontrolnych oraz pasków do glukometrów do Apteki SP ZOZ Szpitala Wielospecjalistycznego w Jaworznie”
Czechia – Specialised chemical products – DNS - chemikálie pro molekulární a buněčnou biologii
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Lithuania – Pharmaceutical products – Vaistų ir kitų farmacijos produktų pirkimas
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications